Drake & Associates LLC Raises Position in UnitedHealth Group Incorporated $UNH

Drake & Associates LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.9% in the 2nd quarter, Holdings Channel.com reports. The fund owned 1,420 shares of the healthcare conglomerate’s stock after buying an additional 310 shares during the quarter. Drake & Associates LLC’s holdings in UnitedHealth Group were worth $443,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Heck Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 27.1% during the second quarter. Heck Capital Advisors LLC now owns 1,859 shares of the healthcare conglomerate’s stock valued at $580,000 after buying an additional 396 shares during the last quarter. KPP Advisory Services LLC boosted its holdings in shares of UnitedHealth Group by 37.9% during the 2nd quarter. KPP Advisory Services LLC now owns 5,300 shares of the healthcare conglomerate’s stock valued at $1,654,000 after acquiring an additional 1,458 shares during the last quarter. D.B. Root & Company LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $528,000. Comprehensive Financial Consultants Institutional Inc. boosted its holdings in UnitedHealth Group by 59.1% in the second quarter. Comprehensive Financial Consultants Institutional Inc. now owns 6,836 shares of the healthcare conglomerate’s stock worth $2,133,000 after purchasing an additional 2,540 shares during the last quarter. Finally, Belpointe Asset Management LLC raised its stake in UnitedHealth Group by 22.5% during the 2nd quarter. Belpointe Asset Management LLC now owns 11,165 shares of the healthcare conglomerate’s stock valued at $3,484,000 after buying an additional 2,051 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on UNH shares. KeyCorp cut their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Bank of America lifted their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Finally, Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Stock Down 0.3%

Shares of UNH stock opened at $358.95 on Tuesday. The company has a market capitalization of $325.09 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.34 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company’s fifty day moving average price is $309.38 and its 200-day moving average price is $352.34. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.